<DOC>
	<DOCNO>NCT00495781</DOCNO>
	<brief_summary>The purpose study define laboratory parameter best suit diagnose functional iron deficiency . Functional iron deficiency condition - due lack iron bioavailability - patient suffers symptoms fatigue weakness , his/her capacity produce red blood cell reduce .</brief_summary>
	<brief_title>Out Come Study To Define Laboratory Parameters That Are Best Suited Diagnose Functional Iron Deficiency</brief_title>
	<detailed_description>In dialysis patient degree anemia highly correlate morbidity mortality . A drop Hb 10 g/L translates increase rate hospitalization 5 6 % rise mortality 4 5 % . The past two decade see great progress treatment renal anemia advent erythropoietin , , recently , darbepoetin . Quite soon , however , become clear , anemia patient chronic renal failure complicate lack bioavailable iron , confers patient partly resistant treatment erythropoietin/darbepoetin . There several parameter use estimate total body iron store diagnosis iron deficiency iron deficiency anemia . Serum iron represent minor fraction total body iron subject major fluctuation due influx efflux tissue iron store . In addition , show great diurnal variability , therefore poor parameter iron deficiency . Iron saturation transporter protein blood , transferrin , similarly difficult interpret , depend also part determination serum iron level . Ferritin , tissue iron storage protein , release circulation active liver cell damage , , quite unlike serum transferrin level , ferritin level rise acute phase response inflammatory reaction . In case , however , serum ferritin level , substantiate concurrent determination C-reactive protein alanine-leucine-aminotransferase ( ALT ) exclude , occult liver cell damage inflammation , correlate well total body iron store total body iron deficiency , respectively . The serum ferritin level , however , poor marker functional iron deficiency erythropoiesis inhibit relative lack bioavailable iron high turnover state bone marrow hemolysis thalassemia . Correspondingly , patient hemochromatosis increase functional iron availability , erythropoiesis augment follow acute blood loss . To date golden standard exist measure functional iron deficiency routine clinical setting . As matter fact , clinical study functional iron deficiency still diagnose indirectly retrospectively effect iron substitution therapy ( increase Hb 10 g/L follow 4 week iron supplementation ) The percentage hemoglobin–deficient , hypochromic erythrocyte , measure hemocytometers , reflect availability iron erythropoiesis become surrogate marker functional iron deficiency . As lifespan erythrocytes varies accord degree patient ’ uremia approximately 60 120 day , hypochromic erythrocyte , measure percentage total erythrocyte ( % -Hypo ) , become detectable late course erythropoietin therapy , therefore think limited sensitivity diagnosis functional iron deficiency . With automated measurement reticulocyte , become possible hemocytometers , Advia 120 , also determine hemoglobin content newly form reticulocyte ( CHr ) . The hemoglobin content reticulocytes mirror closely current availability iron erythropoiesis . What would make CHr attractive clinician clinical laboratory , acclaimed sensitivity detect functional iron deficiency , , even , easy availability , form part simple reticulocyte count normal hemocytometer . In hemocytometric system laser light scatter pattern utilized characterize hemoglobin content reticulocyte ( RET-HE ) . This new parameter , RET-HE , show similar sensitivity specificity CHr give comparable result clinical sample ( CHr , r = 0.94 ) . The present study mean define laboratory parameter ( % -Hypo/CHr RET-He ) suit best diagnose functional iron deficiency . The study design ask parameter physician able diagnose patient improve management anemia . A diagnostic parameter search improve patient ' treatment , measure blood hemoglobin level ( primary end point 1 ) , low possible cost ( primary end point 2 ) .</detailed_description>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>renal anemia , glomerular filtration rate &lt; 10 ml/min therapy either erythropoietin darbepoetin dialysis patient therapy iron cancer autoimmune diseases chronic inflammation liver disease thalassemia , cause anemia ( except renal anemia iron deficiency anemia )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>functional iron deficiency</keyword>
	<keyword>renal anemia</keyword>
	<keyword>dialysis</keyword>
	<keyword>erythropoietin</keyword>
	<keyword>darbepoetin</keyword>
</DOC>